Medasys

Plantagenet Capital has invested a total of FFr 20.6m in Medasys, which is quoted on the unlisted securities market in France. The investment has been made as part of a capital increase for the company and as part of a move to acquire the self-regulating part of the business. The company carries out the computerisation of medical files and provides other services to the medical profession. It generated total sales of FFr 252.3m in 2000 and has around 200 employees. Founded over twenty years ago, Medasys generates a profit and has forecast that it will turnover around FFr 300m in 2001. Yves Couillard, who has taken up a position on the companyÂ’s board, and Guy Zarka coordinated the deal on behalf of Plantagenet, which has acquired a 9% stake in the company. Medasys will now completea programme of external acquisitions and has already been selected as the main supplier to the Georges Pompidou Hospital by the National Health Department.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France